Advancing Gene Therapy Research for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
Glanzmann’s Research Foundation shared a post on LinkedIn:
“More than four years ago, we visited David Wilcox and his team at the Medical College of Wisconsin, where they have spent decades advancing a potential gene therapy cure for GlanzmannThrombasthenia.
Today, we are closer than ever to clinical trials, and we’ll soon be returning to the lab to see firsthand how much progress has been made.
The science is there. The expertise is there.
The biggest barrier to this research reaching patients is funding.
What makes the us so unique as a non-profit in the rare bleeding disorders space is that all donations directly support research to find a cure.
Every donation helps move this promising therapy one step closer to clinical trials.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 13:54Gabrielle Sarlon: Breaking the Silence on Menstrual Bleeding During Anticoagulant Therapy
-
Nov 17, 2026, 13:47Ksenia Guznova Kats: Advanced Venous Stenting in May–Thurner Syndrome
-
Nov 17, 2026, 13:37Abdlemewla Ibrahim: Prasugrel vs Ticagrelor in ACS Patients Undergoing PCI
-
Nov 17, 2026, 13:30Stacy E. Croteau: Oral and Dental Care in Pediatric Patients With Bleeding Disorders
-
Nov 17, 2026, 13:19Efe Saglam: Cannabis Use and Cardiac Conduction
-
Nov 17, 2026, 10:41Elena Petkovic։ Highlights from the ISBT–WHO Plasma Management Workshop
-
Nov 17, 2026, 10:30Cheng-Hock Toh: Haematology Is Everywhere – But Is It Recognised?
-
Nov 17, 2026, 10:23Akshat Jain: The Importance of Knowing Your Sickle Cell Status
-
Nov 17, 2026, 10:12Caitlin Raymond: What Does Apheresis Really Cost?